TY  - CONF

T1  - The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response – exploratory evidence for direct anti-tumor activity in breast cancer.

JO  - Poster Session Abstracts

PY  - 2009/01/15

AU  - Winter MC

AU  - Thorpe HC

AU  - Burkinshaw R

AU  - Beevers SJ

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1158/0008-5472.sabcs-5101

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -